Urinary Tract Specimens that Challenge The (Paris) System

 

Christopher J. VandenBussche, MD, PhD
Associate Professor
The Johns Hopkins University School of Medicine
Baltimore, Maryland

 

While many pathologists are familiar with The Paris System for Reporting Urinary Cytology (TPS), questions often arise regarding the best way to interpret and implement TPS. Degeneration and reactive changes often result in unusual morphologies that can be difficult to classify when TPS criteria are strictly applied. Challenging cases will be presented to allow for a practical assessment and discussion of each case.

Target Audience

This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.

Learning Objectives

  • Identify reactive and degenerative changes that can sometimes cause concern for malignancy
  • Diagnose high grade urothelial carcinoma in specimens that may not meet the formal criteria for malignancy according to TPS
  • Understand the impact of indeterminate diagnoses on patient care
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 MOC II
  • 2.00 Participant
Course opens: 
05/26/2020
Course expires: 
05/31/2023
Cost:
$105.00
Presenter
Christopher J. VandenBussche, MD, PhD
Associate Professor
The Johns Hopkins University School of Medicine
Baltimore, Maryland
 
Disclosure
The speaker has received royalties from Springer Publishing and Wolters‐Kluver.
The speaker’s institution has received grant funding as a subcontractor on an NCI‐SBIR award to Thrive Earlier Detection.
 
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs.  All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program.  Click here for a complete list.
 
ACCREDITATION AND DESIGNATION STATEMENTS

Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

American Board of Pathology Maintenance of Certification (CC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Continuing Certification (CC) process.  Earn up to 2.0 SAM Credit Hours.

Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians.  The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.

Available Credit

  • 2.00 AMA PRA Category 1 Credit™
  • 1.00 California Credits
  • 2.00 CMLE
  • 2.00 Florida Credits
  • 2.00 MOC II
  • 2.00 Participant

Price

Cost:
$105.00
Please login or register to take this course.